How much does a box of pirtobrutinib cost and its price composition

Pirtobrutinib is a new generation BTK inhibitor, mainly used to treat relapsed or refractory mantle cell lymphoma and other B cell-related diseases. At present, the drug has been approved for marketing in China, but due to its short time on the market, it has not yet fully entered the pharmacies or drug supply platforms of major domestic hospitals, making it temporarily difficult for patients to purchase it directly in China. Patients who want to obtain the drug still need to rely on some specialty drug services or choose overseas drug purchase channels.

In overseas markets, Pitobrutinib is produced and sold by the American company Eli Lilly and is divided into two mainstream versions: the American version and the European version. According to the latest price information in 2025, the price of overseas original drugs is about RMB 100,000 per box, and the specifications are usually 50mg 60 tablets or 100mg 30 tablets. Such a high selling price puts great financial pressure on ordinary patients, especially when long-term medication maintenance treatment is required. The cost issue becomes an important factor in whether patients can adhere to medication.

In order to help more patients solve their medication burden, Laos' Lucius (Lucius) pharmaceutical company has successfully produced a generic version of pitobrutinib and received approval from the Lao Ministry of Health for marketing. The specification of this generic drug is 50mg*30 tablets, and the price per box is less than 3000 yuan, which is significantly lower in cost than the original drug. Generic drugs are consistent with the original drugs in terms of ingredients, dosage and dosage, and are suitable for patients who are under financial pressure but urgently need treatment. However, you still need to pay attention to the formality of drug channels when purchasing to ensure that the source of drugs is safe and traceable.

At present, if domestic patients have difficulty obtaining hospital prescriptions to purchase original drugs, they can choose to purchase Lao generic versions through qualified international pharmaceutical platforms. Some channels also provide remote doctor evaluation services. Although generic drugs are more affordable, patients still need to undergo a detailed evaluation by a professional hematologist and develop an individualized treatment plan before use. At the same time, key indicators such as blood picture, liver and kidney function should be reviewed regularly during medication to ensure the safety of treatment. In the future, with the expansion of the promotion scope of pitobrutinib in China, drug prices and convenience of drug purchase are expected to further improve.

Reference materials:https://www.drugs.com/